It’s important to note that obesity itself isn’t an indicator of one’s health, but there are cases, like this one, when it ...

The cancer antigen (CA)-125 tumor marker is a glycoprotein expressed on the cell surface of epithelial ovarian cancer cells; levels are elevated in >80% of newly diagnosed ovarian carcinoma ...

Barlow M, Down L, Mounce LTA, et al. The diagnostic performance of CA-125 for the detection of ovarian cancer in women from different ethnic groups: a cohort study of English primary care data.

HealthDay News — Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis, according to a study published in JAMA Network ...

CA-125, a protein produced by ovarian cancer cells and detectable through a blood test, became the first FDA-approved biomarker for cancer diagnosis and surveillance in 1981.

The researchers analyzed data from more than 200,000 women with ovarian cancer from 2004 through 2020 who’d had a CA-125 blood test.

This expert discusses recent trends in VTE among ovarian cancer patients—progress to date and work that remains to be done. A leading investigator answers our questions about recent findings.